Powered by MOMENTUM MEDIA
lawyers weekly logo
Advertisement
Markets
10 September 2025 by Adrian Suljanovic

Are big banks entering a new cost-control cycle?

Australia’s biggest banks have axed thousands of jobs despite reporting record profits over the year, fuelling concerns over cost-cutting, offshoring ...
icon

How $2.68tn is spread across products and investments

Australia’s $2.68 trillion superannuation system is being shaped not only by the dominance of MySuper and Choice ...

icon

Private credit growth triggers caution at Yarra Capital

As private credit emerges as a fast-growing asset class, Yarra Capital Management remains cautious about the risks that ...

icon

CBA flags end of global rate-cutting cycle

The major bank has indicated that central banks are nearing the end of their rate-cutting cycles, while Trump’s pressure ...

icon

ETF market nears $300bn as international equities lead inflows

The Australian ETF industry is on the cusp of hitting $300 billion in assets under management, with VanEck forecasting ...

icon

Lonsec joins Count in raising doubts over Metrics funds

Lonsec has cut ratings on three Metrics Credit Partners funds, intensifying scrutiny on the private credit manager’s ...

VIEW ALL

GMO, UBS staff defections take mandate toll

  •  
By
  •  
2 minute read

Health fund MBF's financial division, ClearView Retirement Solutions, has dumped GMO Australia and UBS Global Asset Management (UBSGAM) from its Australian shares portfolio.

Health fund MBF's financial division, ClearView Retirement Solutions, has dumped GMO Australia and UBS Global Asset Management (UBSGAM) from its Australian shares portfolio.

ClearView has hired quant manager Dimensional Fund Advisers in their place.

GMO and UBSGAM managed $92 million and $162 million respectively. Dimensional Fund Advisers will manage $190 million.

ClearView's decision to replace UBSGAM and GMO comes at a bad time for both managers, which have lost a series of key staff this year to boutiques.

Former UBSGAM head of Australian equities Paul Fiani left in early 2007 to form his own boutique, Integrity Investment Management. He took portfolio manager Shawn Burns, head of research John Moran and investment analyst Marcus Truman with him.

The manager also lost a $320 million Australian equities mandate with Victorian Funds Management Corporation in September.

GMO lost head of Australian equities Max Cappetta and head of equities research Anthony Corr in September. They left to jointly establish quant boutique Continuum Capital Management with former colleague Brett McElwee.

The manager has lost a series of investment mandates as a result.

ClearView, which is advised by Intech, manages over $2 billion.